Sanofi/Aventis Revise Merger Terms To Reflect Dividend Impact
This article was originally published in The Pink Sheet Daily
Executive Summary
The new agreement follows approval by Aventis shareholders of an €0.82 dividend, payable July 15. Under the revised standard entitlement, shareholders will receive five Sanofi shares and €115.08 in cash for every six Aventis shares.
You may also be interested in...
Sanofi/Aventis Offer To Expire June 30
Sanofi-Synthelabo's offer for Aventis shares will expire June 30 under a deadline set by the French market regulator Autorite des Marches Financiers
Sanofi Wins Aventis With $8 Bil. In Cash And Nominal Joint Control
Sanofi's winning bid for Aventis includes an added $8 bil. in cash, nominal joint control of the merged company, and an acknowledgment of Aventis' Franco-German heritage
Another Chance For VALID? Negative Reaction To FDA’s LDT Proposal May Reopen Legislative Talks
All of the witnesses testifying to a House E&C Committee hearing said they preferred the flexibility and targeted enforcement of the VALID Act to FDA’s proposed rule. Will Congress finally be spurred to act?